Home » AGEB Journal » Issues » Volume 69" » Fasc.3 - Original articles » Article details

The effects of Gingko biloba, vitamin E and melatonin on bacterial translocation in thioacetamide-induced fulminant hepatic failure in rats

Journal Volume 69 - 2006
Issue Fasc.3 - Original articles
Author(s) M.M.M. Harputluoglu, U. Demirel, N. Karadag, I. Temel, M. Bayraktar, S. Firat, D. Karahan, M. Aladag, H. Alan, F. Ates, M. Karincaoglu, F. Hilmioglu
Full article
Full Article
VIEW FREE PDF
Departments of (1) Gastroenterology ; (2) Pathology ; (3) Biochemistry ; (4) Microbiology and (5) Internal Medicine, Inonu University Medical Faculty, Malatya, Turkey.

Background and study aims : Bacterial translocation (BT) has been implicated in the development of infectious complications in many serious clinical conditions such as fulminant hepatic failure (FHF). We aimed to investigate the effects of Gingko biloba (GB), vitamin E (Vit E) and melatonin on intestinal oxidative damage and BT in thioacetamide (TAA)-induced FHF in rats. Materials and methods : A total of 42 rats were divided into five groups. Group 1 (n = 8) was the control group. Group 2 (n = 10) was the TAA group, in which rats received 350 mg/kg TAA daily by the intraperitoneal (ip) route for 3 days. Oral 100 mg/kg GB per day was administered to group 3 (n = 8), oral 200 mg/kg Vit E per day to group 4 (n = 8) and ip 3 mg/kg melatonin per day to group 5 (n = 8) 48 h prior to the first TAA injection and was con- tinued for 5 consecutive days. Results : When compared with the control group, serious hepat- ic and intestinal oxidative damage, increased Escherichia coli counts in ileal aspirates and high BT frequencies were observed in the TAA group (all p < 0.0001). Only GB treatment attenuated hepatic oxidative damage (p < 0.0001). There was no difference in intestinal oxidative damage, E. coli counts in ileal aspirates and BT frequency between TAA and the other antioxidant treatment groups (p > 0.05). Conclusion : Our results suggest that intestinal oxidative dam- age plays a major role in the development of BT by disrupting the barrier function of intestinal mucosa. (Acta gastroenterol. belg., 2006, 69, 268-275).

© Acta Gastro-Enterologica Belgica.